Juan Flores

582 total citations
29 papers, 326 citations indexed

About

Juan Flores is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Juan Flores has authored 29 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Juan Flores's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). Juan Flores is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). Juan Flores collaborates with scholars based in Spain, Puerto Rico and United States. Juan Flores's co-authors include Eulalia Valencia, Javier Ena, Carmen Quereda, C Redondo, Concha Amador, Francisco Pasquau, M. Torres-Tortosa, Julio Arrizabalaga, Mar Masiá and J Lacruz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and CHEST Journal.

In The Last Decade

Juan Flores

24 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Flores Spain 9 160 91 82 59 56 29 326
I. Béguinot France 11 207 1.3× 284 3.1× 148 1.8× 87 1.5× 22 0.4× 24 431
Monica Guffanti Italy 11 206 1.3× 82 0.9× 18 0.2× 22 0.4× 22 0.4× 28 349
M Mannazzu Italy 9 155 1.0× 97 1.1× 31 0.4× 8 0.1× 58 1.0× 14 385
F Mignone Italy 11 176 1.1× 98 1.1× 38 0.5× 105 1.8× 21 0.4× 27 354
Ben J. Childers United States 7 202 1.3× 82 0.9× 369 4.5× 56 0.9× 4 0.1× 8 489
Lori E. Fantry United States 10 138 0.9× 62 0.7× 22 0.3× 40 0.7× 10 0.2× 30 319
Elisa Vanino Italy 10 239 1.5× 166 1.8× 44 0.5× 127 2.2× 22 0.4× 18 348
Elena Vanessa Martínez Sánchez Spain 9 65 0.4× 207 2.3× 30 0.4× 133 2.3× 10 0.2× 29 383
Megan Casey United States 8 89 0.6× 54 0.6× 56 0.7× 32 0.5× 5 0.1× 26 297
Derya Seyman Türkiye 9 97 0.6× 100 1.1× 24 0.3× 32 0.5× 4 0.1× 33 255

Countries citing papers authored by Juan Flores

Since Specialization
Citations

This map shows the geographic impact of Juan Flores's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Flores with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Flores more than expected).

Fields of papers citing papers by Juan Flores

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Flores. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Flores. The network helps show where Juan Flores may publish in the future.

Co-authorship network of co-authors of Juan Flores

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Flores. A scholar is included among the top collaborators of Juan Flores based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Flores. Juan Flores is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ramírez, Margarita, Mar Masiá, Roger Paredes, et al.. (2023). Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses. BMC Infectious Diseases. 23(1). 286–286. 8 indexed citations
3.
Flores, Juan, et al.. (2023). El liderazgo de China en energía solar fotovoltaica y su impacto en el comercio internacional de paneles solares. México y la Cuenca del Pacífico. 13(37). 39–65.
4.
5.
Pasquau, Juan, Carmen Hidalgo-Tenorio, Marisa Montes, et al.. (2018). High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial. PLoS ONE. 13(4). e0195068–e0195068. 30 indexed citations
6.
Deltoro, Miguel García, Juan Flores, Marta Montero, et al.. (2017). Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients. AIDS. 32(3). 337–346. 4 indexed citations
7.
Poveda, Eva, José Hernández‐Quero, Maria Jesús Pérez‐Elías, et al.. (2016). Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48‐week analysis of results from the PROTEST study. HIV Medicine. 18(7). 482–489. 1 indexed citations
8.
García, Féderico, Eva Poveda, Maria Jesús Pérez‐Elías, et al.. (2014). Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48‐week analysis of the PROTEST study. Journal of the International AIDS Society. 17(4S3). 19520–19520. 1 indexed citations
9.
Ortega, Enrique, Juan Flores, Mar Masiá, et al.. (2014). Telaprevir or boceprevir in HIV/HCV‐1 co‐infected patients in a real‐life setting. Interim analysis (24 weeks). COINFECOVA‐SEICV study. Journal of the International AIDS Society. 17(4S3). 19634–19634. 1 indexed citations
10.
Uribe, Natalia, et al.. (2012). Management of giant anal condyloma by wide local excision and anoplasty. Colorectal Disease. 14(11). 1394–1397. 1 indexed citations
11.
Rubio, Rafael, Oscar K. Serrano, Víctor Asensi, et al.. (2010). Effect of simplification from protease inhibitors to boosted atazanavir‐based regimens in real‐life conditions. HIV Medicine. 11(9). 545–553. 14 indexed citations
12.
Pérez‐Elías, Maria Jesús, José María Gatell, Juan Flores, et al.. (2009). Short-Term Effect of Ritonavir-Boosted Atazanavir in Hepatitis B and/or C Co-infected, Treatment-Experienced HIV Patients. HIV Clinical Trials. 10(4). 269–275. 5 indexed citations
13.
Pulido, Federico, Miguel Á. del Pozo, Manuel Fernández Guerrero, et al.. (2008). Patients’ Perception and Effectiveness of a Treatment Containing Enfuvirtide When Used in HIV-Infected Patients Without Very Advanced Disease. HIV Clinical Trials. 9(2). 83–90. 3 indexed citations
14.
Mallolas, Josep, Judit Pich, Joan Albert Arnáiz, et al.. (2007). A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients. Revista Clínica Española. 207(9). 427–432. 6 indexed citations
15.
Berenguer, Juan, Maria Jesús Pérez‐Elías, José M. Bellón, et al.. (2006). Effectiveness and Safety of Abacavir, Lamivudine, and Zidovudine in Antiretroviral Therapy-Naive HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(2). 154–159. 15 indexed citations
16.
Gutiérrez, Félix, Sergio Padilla, Mar Masiá, et al.. (2006). Osteonecrosis in Patients Infected With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(3). 286–292. 33 indexed citations
17.
Uribe, Natalia, et al.. (2004). Excision and V–Y plasty reconstruction for giant condyloma acuminatum. Techniques in Coloproctology. 8(2). 99–101. 15 indexed citations
18.
Torres-Tortosa, M., et al.. (2003). Prognosis and Clinical Evaluation of Infection Caused by Rhodococcus equi in HIV-Infected Patientsa. CHEST Journal. 123(6). 1970–1976. 64 indexed citations
19.
Gutiérrez, Félix, Sergio Padilla, Enrique Ortega, et al.. (2002). Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors. AIDS. 16(3). 481–483. 29 indexed citations
20.
Flores, Juan. (1999). El colonialismo "lite": diversiones de un discurso puertorriqueño. Revista De Ciencias Sociales. 7(7). 1–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. Béguinot Breakdown of academic impact, for papers by Monica Guffanti Breakdown of academic impact, for papers by M Mannazzu Breakdown of academic impact, for papers by F Mignone Breakdown of academic impact, for papers by Ben J. Childers Breakdown of academic impact, for papers by Lori E. Fantry Breakdown of academic impact, for papers by Elisa Vanino Breakdown of academic impact, for papers by Elena Vanessa Martínez Sánchez Breakdown of academic impact, for papers by Megan Casey Breakdown of academic impact, for papers by Derya Seyman
Rankless by CCL
2026